← Back to Search

Mobile Health Support for Substance Use Reduction (QUIT-Mobile Trial)

N/A

Recruiting

Led By Lillian Gelberg, MD, MSPH

Research Sponsored by University of California, Los Angeles

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12-month follow-up

Awards & highlights

QUIT-Mobile Trial Summary

This trial will test whether using a mobile phone to monitor and give feedback on drug use will help reduce risky drug use better than just providing standard brief intervention and advice or than doing nothing special.

Who is the study for?

This trial is for adults over 18 with moderate drug use, as indicated by an ASSIST score of 4-26, who have used substances in the past month. Participants must be receiving care at study clinics, speak English or Spanish, and plan to stay in Los Angeles for a year. Pregnant women, those already in substance treatment programs or with severe substance use disorders are excluded.Check my eligibility

What is being tested?

The QUIT-Mobile study tests if mobile phone self-monitoring can improve and maintain reduced risky drug use over a year after the initial QUIT intervention. It's a three-arm RCT comparing QUIT-Mobile (mobile-web app or texts), standard QUIT (brief advice and health coaching), and usual care.See study design

What are the potential side effects?

Since this trial involves behavioral interventions rather than medications, traditional side effects are not expected. However, participants may experience discomfort from discussing personal substance use habits during counseling sessions.

QUIT-Mobile Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12-month follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12-month follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Drug Use

Secondary outcome measures

30-day Timeline Follow Back (TLFB) of Drug Use

Health Service Utilizations

Health-related Quality of Life Improvement Self-Reports (MHI)

+2 more

QUIT-Mobile Trial Design

3Treatment groups

Experimental Treatment

Group I: Usual CareExperimental Treatment1 Intervention

Usual Care participants will receive their standard medical care as usual (no provider advice or telephone coaching sessions) and all screening and study assessments. To reduce biases, Usual Care arm patients will be given a cancer screening booklet and will be shown a cancer screening Video Doctor. They will also receive 2 re-contact telephone sessions at weeks 2 and 6 corresponding to the timing of the coaching sessions for the QUIT and QUIT-Mobile arms. All participants will also receive re-contact calls monthly from 7-weeks to 12-months. The re-contact calls (5 min) provide attention control for the Usual Care arm, motivate continued trial participation by reminding them of the next research assessment, but do not provide an active intervention. At study end, the Usual Care arm will receive the QUIT video doctor and drug use reduction booklet brochure materials including overdose prevention materials and a list of clinic/community resources to help them reduce substance use.

Group II: QUIT-MobileExperimental Treatment1 Intervention

QUIT-Mobile will include a mobile platform with self-monitoring surveys and feedback message and robust data transfer protocols across three mobile technology platforms to meet diverse patient's preferences and needs regardless of literacy and phone type: a mobile-optimized web-app (using any smart phone's web-browser, not "native" apps), SMS (text-messaging), and IVR (automated voice calls for low literacy patients). Data collected during this study on patient platform preferences and exploratory analyses on intervention efficacy across platform types will inform the development of future effectiveness trials that can evaluate effectiveness of different mobile platforms.

Group III: QUITExperimental Treatment1 Intervention

The QUIT brief intervention protocol will consist of 5 steps corresponding to the 5A's approach for assisting behavior change in the clinic setting (Ask, Advise, Assess, Assist, and Arrange) that will focus on patients' HSD (highest scoring drug on the baseline ASSIST) use in the past 30 days.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Usual Care

1990

Completed Phase 4

~7700

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor

1,532 Previous Clinical Trials

10,264,308 Total Patients Enrolled

7 Trials studying Substance Use

3,731 Patients Enrolled for Substance Use

National Institute on Drug Abuse (NIDA)NIH

2,470 Previous Clinical Trials

2,618,770 Total Patients Enrolled

68 Trials studying Substance Use

37,926 Patients Enrolled for Substance Use

University of ArkansasOTHER

486 Previous Clinical Trials

149,393 Total Patients Enrolled

Media Library

QUIT Intervention (doctor brief advice, video doctor, health coaching sessions at 2- and 6-weeks) Clinical Trial Eligibility Overview. Trial Name: NCT04935606 — N/A

Substance Use Research Study Groups: Usual Care, QUIT, QUIT-Mobile

Substance Use Clinical Trial 2023: QUIT Intervention (doctor brief advice, video doctor, health coaching sessions at 2- and 6-weeks) Highlights & Side Effects. Trial Name: NCT04935606 — N/A

QUIT Intervention (doctor brief advice, video doctor, health coaching sessions at 2- and 6-weeks) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04935606 — N/A

Substance Use Patient Testimony for trial: Trial Name: NCT04935606 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open spots remaining in this experiment?

"That is accurate. According to the records on clinicaltrials.gov, this medical trial was initially posted in June 2021 and updated as recently as March 2022. The investigation seeks 960 individuals from 2 distinct health centres for inclusion."

Answered by AI

What is the recruitment capacity of this research?

"Affirmative. Clinicaltrials.gov has corroborated that this clinical trial was posted on June 1st 2021 and last amended on March 11th 2022; it is currently searching for 960 participants across two sites."

Answered by AI

Who else is applying?

What state do they live in?

Texas

Kansas

What site did they apply to?

Saban Community Clinic

What portion of applicants met pre-screening criteria?

Met criteria

How many prior treatments have patients received?

Why did patients apply to this trial?

I love knowing that I could help others and make a difference. The consequences from being a substance abuse user has always negatively effected myself and others around me. Being able to provide a positive outcome, help someone,or even just making a difference in a good way I feel is the least I could due after all the damage that has been done from using drugs.

PatientReceived no prior treatments